Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. (Q40475372)

20 September 2017

1 reference

title

Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. (English)

1 reference

20 September 2017

Pappot H

1

1 reference

20 September 2017

Gårdsvoll H

2

1 reference

20 September 2017

Rømer J

3

1 reference

20 September 2017

Pedersen AN

4

1 reference

20 September 2017

Grøndahl-Hansen J

5

1 reference

20 September 2017

Pyke C

6

1 reference

20 September 2017

Brünner N

7

1 reference

20 September 2017

publication date

1 May 1995

1 reference

Biological chemistry Hoppe-Seyler

20 September 2017

published in

1 reference

20 September 2017

volume

376

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

259-267

1 reference

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Type-1 plasminogen activator inhibitor in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Differential protease expression by cutaneous squamous and basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Cellular receptor for urokinase-type plasminogen activator: protein structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Plasminogen receptors on rat colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The extracellular regulation of growth factor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Structure of a soluble, glycosylated form of the human complement regulatory protein CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The urokinase receptor is required for human monocyte chemotaxis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Nature of the interaction of growth factors with suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Processing of complex between urokinase and its type-2 inhibitor on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Molecular cloning of cDNA for the bovine urokinase-type plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

The plasminogen activator/plasmin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

Membrane proteases in focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.5.259

10.1515/BCHM3.1995.376.5.259

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference